E-LIB Suche - Ergebnisse für: Pylväläinen, Juho

1

Risk of Clinically Significant Prostate Cancer after a Nons..:

Pylväläinen, Juho ; Hoffström, Jaakko ; Kenttämies, Anu...
Cancer Epidemiology, Biomarkers & Prevention. 33 (2024) 5 - p. 749-756 , 2024

Link: https://doi.org/10.1158/..

2

Histomic and transcriptomic features of MRI‐visible and inv..:

Lehto, Timo‐Pekka K. ; Pylväläinen, Juho ; Sandeman, Kevin...
International Journal of Cancer. 154 (2023) 5 - p. 926-939 , 2023

Link: https://doi.org/10.1002/..

3

Patients' education level and treatment modality for prosta..:

Kilpeläinen, Tuomas P. ; Talala, Kirsi ; Taari, Kimmo...
European Journal of Cancer. 130 (2020) - p. 204-210 , 2020

Link: https://doi.org/10.1016/..

4

Association between grayscale sonographic and clinical find..:

Kauppinen, Kyösti ; Pylväläinen, Juho ; Pamilo, Konsta...
Journal of Clinical Ultrasound. 48 (2019) 2 - p. 75-81 , 2019

Link: https://doi.org/10.1002/..

5

Charlson Comorbidity Index Based On Hospital Episode Statis..:

Pylväläinen, Juho ; Talala, Kirsi ; Murtola, Teemu...
Clinical Epidemiology. 11 (2019) - p. 923-932 , 2019

Link: https://doi.org/10.2147/..

6

Ultrasonography of the late-stage knee osteoarthritis prior..:

Nevalainen, Mika T. ; Kauppinen, Kyösti ; Pylväläinen, Juho...
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

7

Prognostic factors of prostate cancer mortality in a Finnis..:

Neupane, Subas ; Steyerberg, Ewout ; Raitanen, Jani...
International Journal of Urology. 25 (2017) 3 - p. 270-276 , 2017

Link: https://doi.org/10.1111/..

8

Histomic and transcriptomic features of MRI-visible and inv..:

Lehto, Timo-Pekka K ; Pylväläinen, Juho ; Sandeman, Kevin...
Lehto , T-P K , Pylväläinen , J , Sandeman , K , Kenttämies , A , Nordling , S , Mills , I G , Tang , J , Mirtti , T & Rannikko , A 2024 , ' Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis ' , International Journal of Cancer , vol. 154 , no. 5 , pp. 926-939 . https://doi.org/10.1002/ijc.34743. , 2024

Link: https://pure.qub.ac.uk/e..

9

Histomic and transcriptomic features of MRI-visible and inv..:

Lehto, Timo-Pekka K ; Pylväläinen, Juho ; Sandeman, Kevin...
10.1002/ijc.34743. , 2023

Link: http://hdl.handle.net/10..

10

Charlson Comorbidity Index Based On Hospital Episode Statis..:

Pylväläinen, Juho ; Talala, Kirsi ; Murtola, Teemu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805117/. , 2019

Link: http://www.ncbi.nlm.nih...

11

Ultrasonography of the late-stage knee osteoarthritis prior..:

Nevalainen, Mika T ; Kauppinen, Kyösti ; Pylväläinen, Juho...
10.1038/s41598-018-35824-3. , 2019

Link: http://hdl.handle.net/10..

12

Charlson Comorbidity Index Based On Hospital Episode Statis..:

Pylväläinen, Juho ; Talala, Kirsi ; Murtola, Teemu...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CLEP.S218697. , 2019

Link: https://www.dovepress.co..

13

Charlson Comorbidity Index Based On Hospital Episode Statis..:

Pylväläinen, Juho ; Talala, Kirsi ; Murtola, Teemu...
1179-1349. , 2019

Link: https://trepo.tuni.fi/ha..

14

Charlson Comorbidity Index Based On Hospital Episode Statis..:

Pylväläinen, Juho ; Talala, Kirsi ; Murtola, Teemu...
10.2147/CLEP.S218697. , 2019

Link: http://hdl.handle.net/10..

15

Ultrasonography of the late-stage knee osteoarthritis prior..:

Nevalainen, M. T. (Mika T.) ; Kauppinen, K. (Kyösti) ; Pylväläinen, J. (Juho)... , 2018

Link: http://urn.fi/urn:nbn:fi..